ArticleCancer research2011

Reduced SMAD7 leads to overactivation of TGF-beta signaling in MDS that can be reversed by a specific inhibitor of TGF-beta receptor I kinase.

Li Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.